Clinical trial
The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine
NCT03746106 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 28, 2019
- Completion date
- August 10, 2023
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thiamine deficiency, vitamin b1 deficiency